Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Yeonsoo, Baik"'
Publikováno v:
Public Health in Practice, Vol 7, Iss , Pp 100483- (2024)
Objectives: In the United States, a federal emergency program has made SARS-CoV-2 self-test kits available at no cost. It is unclear how widely free tests are preferred. We conducted a survey to estimate the proportion of respondents who do not prefe
Externí odkaz:
https://doaj.org/article/8808d654ac444ff3b226412337afad4c
Autor:
Fred C Semitala, Jillian L Kadota, Allan Musinguzi, Fred Welishe, Anne Nakitende, Lydia Akello, Lynn Kunihira Tinka, Jane Nakimuli, Joan Ritar Kasidi, Opira Bishop, Suzan Nakasendwa, Yeonsoo Baik, Devika Patel, Amanda Sammann, Payam Nahid, Robert Belknap, Moses R Kamya, Margaret A Handley, Patrick Pj Phillips, Anne Katahoire, Christopher A Berger, Noah Kiwanuka, Achilles Katamba, David W Dowdy, Adithya Cattamanchi
Publikováno v:
PLoS Medicine, Vol 21, Iss 2, p e1004356 (2024)
BackgroundExpanding access to shorter regimens for tuberculosis (TB) prevention, such as once-weekly isoniazid and rifapentine taken for 3 months (3HP), is critical for reducing global TB burden among people living with HIV (PLHIV). Our coprimary hyp
Externí odkaz:
https://doaj.org/article/5761700085894911af073cb22efadc18
Autor:
Allan Musinguzi, Joan R Kasidi, Jillian L Kadota, Fred Welishe, Anne Nakitende, Lydia Akello, Jane Nakimuli, Lynn T Kunihira, Bishop Opira, Yeonsoo Baik, Devika Patel, Amanda Sammann, Christopher A Berger, Hélène E Aschmann, Payam Nahid, Robert Belknap, Moses R Kamya, Margaret A Handley, Patrick P J Phillips, Noah Kiwanuka, Achilles Katamba, David W Dowdy, Adithya Cattamanchi, Fred C Semitala, Anne R Katahoire
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 10, p e0003347 (2024)
Three months of isoniazid-rifapentine (3HP) is being scaled up for tuberculosis (TB) preventive treatment (TPT) among people living with HIV (PLHIV) in high-burden settings. More evidence is needed to identify factors influencing successful 3HP deliv
Externí odkaz:
https://doaj.org/article/41e77009facc4c0783714fa4d40e15f8
Autor:
Yeonsoo Baik, Pholo Maenetje, Diana Schramm, Caroline Tiemessen, Itai Ncube, Gavin Churchyard, Robert Wallis, Mboyo-di-tamba Vangu, Hardy Kornfeld, Yun Li, Sara C. Auld, Gregory P. Bisson
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Patients with tuberculosis (TB) and HIV often present with impairments in lung function and exercise capacity after treatment. We evaluated clinical and immunologic variables associated with a minimum clinically important differen
Externí odkaz:
https://doaj.org/article/19eaeaebfb4c4c90a81280d5baa856f7
Publikováno v:
Epidemics, Vol 41, Iss , Pp 100631- (2022)
Background: Diagnostic testing plays a critical role in the global COVID-19 response. Polymerase chain reaction (PCR) tests are highly accurate, but in resource-limited settings, limited capacity has led to testing delays; whereas lateral flow assays
Externí odkaz:
https://doaj.org/article/f5baec72722e47a2a2fae434efd4414e
Autor:
Yeonsoo Baik, Chawangwa Modongo, Patrick K. Moonan, Eleanor S. Click, James L. Tobias, Rosanna Boyd, Alyssa Finlay, John E. Oeltmann, Sanghyuk S. Shin, Nicola M. Zetola
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 5, Pp 953-960 (2020)
Tuberculosis caused by concurrent infection with multiple Mycobacterium tuberculosis strains (i.e., mixed infection) challenges clinical and epidemiologic paradigms. We explored possible transmission mechanisms of mixed infection in a population-base
Externí odkaz:
https://doaj.org/article/3b57b7b8978c4501b0907c86c05e875f
Autor:
Mabel Michille Kimble, Marjan Javanbakht, Kara W. Chew, Chrysovalantis Stafylis, Di He, Samantha Ramirez, Yeonsoo Baik, Sammy Saab, Jeffrey D. Klausner
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background In the United States Hepatitis C virus (HCV) viral clearance is estimated to range between 20 and 30%. The objective of this study was to estimate the frequency of HCV clearance and identify correlates of viral clearance among pat
Externí odkaz:
https://doaj.org/article/201cffaed2024e21aa65f502fe9c038e
Autor:
Katherine O Robsky, David Isooba, Olga Nakasolya, James Mukiibi, Annet Nalutaaya, Peter J Kitonsa, Caleb Kamoga, Yeonsoo Baik, Emily A Kendall, Achilles Katamba, David W Dowdy
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251806 (2021)
BackgroundInternational and internal migration are recognized risk factors for tuberculosis (TB). Geographic mobility, including travel for work, education, or personal reasons, may also play a role in TB transmission, but this relationship is poorly
Externí odkaz:
https://doaj.org/article/ad098836b1a44c52b94f8f5647d980e3
Autor:
Yeonsoo Baik, Hannah M Rickman, Colleen F Hanrahan, Lesego Mmolawa, Peter J Kitonsa, Tsundzukana Sewelana, Annet Nalutaaya, Emily A Kendall, Limakatso Lebina, Neil Martinson, Achilles Katamba, David W Dowdy
Publikováno v:
PLoS Medicine, Vol 17, Iss 11, p e1003420 (2020)
BackgroundIn highly resource-limited settings, many clinics lack same-day microbiological testing for active tuberculosis (TB). In these contexts, risk of pretreatment loss to follow-up is high, and a simple, easy-to-use clinical risk score could be
Externí odkaz:
https://doaj.org/article/ef6ca963c79f42a78a6ebc5d95a69ad5
Autor:
Peter J Kitonsa, Annet Nalutaaya, James Mukiibi, Olga Nakasolya, David Isooba, Caleb Kamoga, Yeonsoo Baik, Katherine Robsky, David W Dowdy, Achilles Katamba, Emily A Kendall
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243542 (2020)
BackgroundWhen evaluating symptomatic patients for tuberculosis (TB) without access to same-day diagnostic test results, clinicians often make empiric decisions about starting treatment. The number of TB symptoms and/or underweight status could help
Externí odkaz:
https://doaj.org/article/e74569e6331b4af2895d16e8193b47f0